FMC and ChemAxon Announce Licensing of ChemAxon's Product Line
News Mar 03, 2006
ChemAxon and FMC Corporation have announced global licensing of ChemAxon's complete product line and the switch over of FMC Agricultural Products Group's structure search platform to ChemAxon's JChem cheminformatics platform.
Through the global acquisition of ChemAxon's toolkits FMC is able to implement cheminformatics platforms useful for insilico structure design, screening, property prediction and management.
The migration of the structure search at FMC's Agricultural Products Group is the first step in this integration.
"FMC's APG Discovery Research has evaluated ChemAxon's products, JChem and Marvin, and found the products to be intuitive, easy to use, reliable, and scalable," said Dr. Ann Orth, Research Director for FMC's Agricultural Products Group.
"In FMC's opinion, ChemAxon's tools are technically sound and are enterprise solutions. More importantly, the evaluation has, in FMC's opinion, shown that the search results from JChem Cartridge are more chemically precise and logical than those from the existing search engine."
"FMC has found that ChemAxon’s other software products are also very useful and interesting. In addition, the cost of purchasing and maintaining ChemAxon’s products is very competitive and ChemAxon’s customer service and technical support are among the best that FMC has found."
"As a result, FMC's APG Discovery Research has moved its structure search platform to the ChemAxon platform."
"We are very pleased to be working with an organisation like FMC, we were particularly happy with the fast and straightforward platform changeover process," commented Ferenc Csizmadia, CEO of ChemAxon.
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018